Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

IMDXIMDX
Showing 8 of 12 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in ONCOCYTE CORP

GEODE CAPITAL MANAGEMENT, LLC holds 256,903 shares of IMDX (ONCOCYTE CORP), worth $1.5M as of 2026-Q2. The position was decreased (-2.0% shares). IMDX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$1.5M

Current Shares

256,903

Total Value Change

+$1.2M

Total Shares Change

+152,923

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
256,903
-2.0%
$1.5M0.0%$5.90
0
2026-Q1
Increased
262,053
+13.5%
$860,1700.0%$5.45
28
2025-Q4
Increased
230,971
+16.4%
$1.7M0.0%$7.00
30
2025-Q3
Increased
198,453
+25.9%
$658,9370.0%$3.23
21
2025-Q2
Decreased
157,580
-0.8%
$475,9530.0%$3.20
0
2025-Q1
Increased
158,907
+15.9%
$486,3310.0%$3.21
19
2024-Q4
Increased
137,069
+31.8%
$326,2820.0%$2.45
20
2024-Q3
Increased
103,980
+12.2%
$296,4000.0%$2.88
18

Other major holders of IMDX: VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used